ExpertiseUpdated on 30 March 2026
SPR characterization of innovative therapeutics
About
Kimialys leverages its proprietary chip functionalization technology to generate clear-cut and reliable SPR characterization data for innovative therapeutics and targets (VHHs, bispecifics, protein aggregates, GPCR, EVs) in any type of biological matrix (plasma, cell extract, and so forth).
We support biotech and big pharma across Europe and North America, carrying out SPR analyses on our own, or helping SPR teams achieve challenging experiments.
Organisation
Similar opportunities
Expertise
Perfused, vascularized 3D human tumour tissue models for predictive preclinical testing
- Nano and Microtechnologies
- Biotech, Pharma and Cosmetics
Karolina Valente
CEO at VoxCell BioInnovation
Victoria, Canada
Partnership
Strategic partnerships for vascularized 3D tumour models in preclinical oncology
Karolina Valente
CEO at VoxCell BioInnovation
Victoria, Canada
Expertise
CDMO End to End Services for Mammalian Cell Based Biologics
- Other
- Healthcare
- Biotech, Pharma and Cosmetics
Diksha Gupta
Head of Global Business Development and Marketing at Kemwell Biopharma
Bengaluru, India